Exact Mass: 551.2532418000001

Exact Mass Matches: 551.2532418000001

Found 500 metabolites which its exact mass value is equals to given mass value 551.2532418000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Endoxifen O-glucuronide

3,4,5-trihydroxy-6-[4-(1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenylbutyl)phenoxy]oxane-2-carboxylic acid

C31H37NO8 (551.2519042)

Endoxifen O-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

Akt inhibitor VIII

1-{1-[(4-{7-phenyl-5H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one

C34H29N7O (551.2433464)

AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2119 nM, respectively.

Arg Phe Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-hydroxybutanamido]pentanedioic acid

C24H37N7O8 (551.2703482000001)

Phe Val Ser Glu Ala

C25H37N5O9 (551.2591152)

Phe Arg Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]pentanedioic acid

C24H37N7O8 (551.2703482000001)

Glu Pro Gly Tyr Ser

C24H33N5O10 (551.2227318)

Phe Asp Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]butanedioic acid

C23H33N7O9 (551.2339648000001)

Tyr Arg Val Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]butanedioic acid

C24H37N7O8 (551.2703482000001)

Thr Arg Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]pentanedioic acid

C24H37N7O8 (551.2703482000001)

Val Tyr Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C24H37N7O8 (551.2703482000001)

Gly Lys Ser Asn Phe

C24H37N7O8 (551.2703482000001)

Glu Thr Phe Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C24H37N7O8 (551.2703482000001)

Leu Gln Tyr Asp

C25H37N5O9 (551.2591152)

Pro Phe Met Thr Gly

C25H37N5O7S (551.2413572)

Gln Ile Tyr Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C25H37N5O9 (551.2591152)

Ala Glu Phe Trp

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H33N5O7 (551.2379868)

Ala Glu Trp Phe

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C28H33N5O7 (551.2379868)

Ala Phe Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C28H33N5O7 (551.2379868)

Ala Phe Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C28H33N5O7 (551.2379868)

Ala Ile Trp Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid